Itron (NASDAQ:ITRI) Now Covered by Analysts at Needham & Company LLC

Research analysts at Needham & Company LLC started coverage on shares of Itron (NASDAQ:ITRI) in a report released on Friday,Benzinga reports. The firm set a “buy” rating and a $124.00 price target on the scientific and technical instruments company’s stock. Needham & Company LLC’s price target would indicate a potential upside of 35.94% from the stock’s current price.

ITRI has been the topic of several other research reports. Weiss Ratings downgraded Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Guggenheim set a $155.00 target price on Itron in a research report on Friday, February 13th. Zacks Research upgraded Itron from a “strong sell” rating to a “hold” rating in a report on Thursday, February 26th. Johnson Rice raised Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a research note on Monday, January 5th. Finally, Oppenheimer lifted their target price on shares of Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Eight equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Itron currently has a consensus rating of “Moderate Buy” and an average price target of $137.10.

Itron Stock Performance

NASDAQ:ITRI opened at $91.22 on Friday. Itron has a twelve month low of $88.57 and a twelve month high of $142.00. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45. The stock’s 50-day simple moving average is $97.59 and its 200 day simple moving average is $108.21. The firm has a market capitalization of $4.10 billion, a PE ratio of 14.01, a price-to-earnings-growth ratio of 0.80 and a beta of 1.44.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.19 by $0.27. The company had revenue of $571.66 million for the quarter, compared to the consensus estimate of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The firm’s quarterly revenue was down 6.7% compared to the same quarter last year. During the same period last year, the company posted $1.35 EPS. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, analysts anticipate that Itron will post 5.33 EPS for the current fiscal year.

Insiders Place Their Bets

In other Itron news, CAO David Marshall Wright sold 264 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $26,444.88. Following the completion of the sale, the chief accounting officer owned 9,124 shares of the company’s stock, valued at approximately $913,951.08. This represents a 2.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Laurie Ann Pulatie-Hahn sold 729 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $100.17, for a total transaction of $73,023.93. Following the completion of the transaction, the senior vice president owned 32,950 shares in the company, valued at $3,300,601.50. This trade represents a 2.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 51,180 shares of company stock valued at $5,085,475 over the last three months. Insiders own 1.45% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Campbell & CO Investment Adviser LLC acquired a new position in shares of Itron during the 3rd quarter valued at $1,300,000. Robeco Schweiz AG increased its stake in Itron by 31.2% in the third quarter. Robeco Schweiz AG now owns 372,176 shares of the scientific and technical instruments company’s stock valued at $46,358,000 after purchasing an additional 88,504 shares in the last quarter. Schroder Investment Management Group increased its stake in Itron by 23.6% in the second quarter. Schroder Investment Management Group now owns 376,087 shares of the scientific and technical instruments company’s stock valued at $49,504,000 after purchasing an additional 71,702 shares in the last quarter. J. Safra Sarasin Holding AG acquired a new position in shares of Itron during the third quarter valued at about $4,673,000. Finally, Envestnet Asset Management Inc. boosted its position in shares of Itron by 34.0% during the 3rd quarter. Envestnet Asset Management Inc. now owns 148,317 shares of the scientific and technical instruments company’s stock worth $18,474,000 after purchasing an additional 37,634 shares in the last quarter. 96.19% of the stock is owned by institutional investors.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.